(Monday, September 20, 2021) – As COVID-19 continues to soar among children, there’s news this morning that a vaccine may be near for youngsters ages 5 to 11.  Pfizer announced Monday its vaccine is safe and effective for that age group and the pharmaceutical is moving to seek U.S. approval by the end of the month.

A lower dose of the vaccine, one-third of the amount given to teens and adults, is said to be safe and provides a robust immune response in children as young as 5.

The findings come as COVID cases among children now account for more than 30% of new infections in the U.S.

Pfizer’s vaccine for elementary aged youngsters must still clear several hurdles, including submitting the data to the Food and Drug Administration.